This activity is intended for psychiatrists, family medicine/primary care clinicians, internists, nurses, pharmacists, and other members of the health care team who treat and manage patients with eating disorders.
The goal of this activity is to describe the association of alcohol use disorders and other substance use disorders with mortality in anorexia nervosa, bulimia nervosa, and unspecified eating disorder compared with matched control subjects, based on a retrospective cohort study using Danish nationwide registers.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-036-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 2/25/2022
Valid for credit through: 2/25/2023, 11:59 PM EST
processing....
Individuals with eating disorders often have comorbid substance use disorders (SUDs); both are linked to excess mortality. Eating disorder and SUD types vary in lethality. New research has shown that patients with an eating disorder who abused alcohol, cannabis, hard drugs, or other combinations had a much higher risk of dying from any cause than those with eating disorders and no SUDs. Additionally, this data has shown that comprehensive assessment of SUDs in those with eating disorders is an early and vital step in improving treatment effectiveness. Members of the healthcare team play an integral role in screening and addressing both eating disorders and SUDs, which can ultimately improve outcomes and save lives.
SUDs, particularly alcohol abuse, are linked to excess mortality in patients with eating disorders, new research shows.
The findings, led by Angelina Mellentin, PhD, from the University of Southern Denmark, Odense, showed that comorbid SUDs were tied to up to an 11-fold increased risk for death across all eating disorder types.
"Control subjects with SUDs also exhibited an elevated risk of all-cause mortality relative to control subjects without SUDs, although to a much lesser extent than eating disorder patients with SUDs," the researchers write.
The study was published online January 1 in The American Journal of Psychiatry.
High MortalityEating disorders are associated with high mortality, but the contribution of comorbid SUDs is unclear.
Using Danish nationwide registers, the researchers analyzed data on 20,759 patients with eating disorders.
The cohort included 8108 patients with anorexia nervosa (AN), 5485 patients with bulimia nervosa (BN), and 7166 patients with unspecified eating disorder, as well as 83,036 matched controls without an eating disorder.
The researchers compared all-cause mortality risk between patients with eating disorders and control patients both with and without a lifetime SUD diagnosis, which included abuse or dependence of alcohol, cannabis, or hard drugs.
Rates of each type of SUD were significantly higher for patients with eating disorders than control patients (alcohol: 4.7% vs 1.0%; cannabis: 4.3% vs 1.3%; hard drugs: 4.7% vs 1.3%), the researchers report.
Patients with any eating disorder but no SUD had an elevated risk for all-cause mortality (adjusted hazard ratio [aHR]: 2.85), as well as mortality from both external causes (aHR: 3.02) and internal causes (aHR: 2.78) compared with control subjects without an eating disorder or SUD.
SUD comorbidity affected mortality risk in patients with any eating disorder.
Patients with an eating disorder who abused alcohol, cannabis, hard drugs, or various combinations had a much higher risk of dying from any cause, with hazard ratios ranging from 4.55 to 22.99, than their counterparts with eating disorders and no SUDs.
"Interestingly," the investigators note, patients with eating disorders who abused alcohol alone had a higher risk (subhazard ratio: 11.35) than patients with eating disorders who abused hard drugs alone (subhazard ratio: 4.74) or hard drugs combined with alcohol (subhazard ratio: 9.68).
There is consistent evidence that both eating disorders and alcohol use disorder cause "considerable physical damage. Indeed, alcohol has been found to cause more physical damage than certain hard drugs such as cocaine and other stimulants, which may explain our results," the investigators write.
Control patients with SUDs also had an elevated risk for all-cause mortality relative to control patients without SUDs, but to a much less extent than patients with eating disorders with SUDs.
"These findings highlight the importance of focusing on the prevention and treatment of SUDs to reduce excess mortality in eating disorder patients," the researchers write.
"This is particularly relevant for AN patients who abuse hard drugs, since they were found to be the most susceptible to premature death," they add.
In BN, SUD appears to be the "driving factor" behind mortality, "and thus the prevention and treatment of SUDs would go a long way toward reducing mortality in BN," they add.
A Deadly CombinationCommenting on the study for Medscape Medical News, Kamryn T. Eddy, PhD, codirector of the Eating Disorders Clinical and Research Program, Massachusetts General Hospital, and associate professor, Department of Psychiatry, Harvard Medical School, Boston, said the "findings from this large, population-based study support what is well-known in the literature: individuals with eating disorders--and in particular AN--are at increased risk for premature death.
"Importantly, these data highlight the most vulnerable group--that is, those with eating disorders and comorbid alcohol, cannabis, or other drug use disorders," said Dr Eddy, who was not involved in the study.
The research also shows that the combination of these disorders "can be deadly, and that the risk is additive; that is, having an eating disorder and 1 substance use problem is bad, but that having 2 is worse, and 3 is worse still," Dr Eddy added.
"For clinicians, these data should absolutely underscore that comprehensive assessment of substance use disorders in those with eating disorders is critical," Dr Eddy added.
"Clinical research must determine mechanisms, such as impulsivity or altered reward responsiveness, that drive both eating and substance use disorders, which we can address in order to improve treatment effectiveness and save lives," she said.
Also weighing in, Stephen Wonderlich, PhD, cochair of the research advisory board, National Eating Disorders Association, said, "The basic finding that [SUDs] contribute substantially to elevated mortality rates in both [AN and BN] is important.
"I do think that most clinical programs assess reasonably carefully for substance use of various kinds. This study suggests that such screening is even more imperative than we may have thought previously," said Dr Wonderlich, Chester Fritz Distinguished Professor, Department of Psychiatry and Behavioral Science, University of North Dakota School of Medicine and Health Sciences, in Fargo.
"The take-home message is fairly clear: If an individual has a significant eating disorder and on top of that has a significant [SUD], the outcomes are likely to be more negative, including increased risk of death. Clinicians and patients should be aware of this," Dr Wonderlich added.
This study was supported by the Psychiatric Research Foundation, University of Southern Denmark, Region of Southern Denmark. Dr Mellentin, Dr Eddy, and Dr Wonderlich have disclosed no relevant financial relationships.
Am J Psychiatry. Published online January 1, 2022.[1]